A Nationwide multicenter registry and biobank program for deep phenotyping of idiopathic and hereditary pulmonary arterial hypertension in Korea: the PAH platform for deep phenotyping in Korean subjects (PHOENIKS) cohort
- Authors
- 장영우; 김성식; 박수정; 최한울; 오병천; 오세연; 김경희; 김계훈; 변경희; 정욱진
- Issue Date
- Sep-2019
- Publisher
- 대한고혈압학회
- Keywords
- Keywords: Pulmonary arterial hypertension; Precision medicine; Blood bank; registries
- Citation
- Clinical Hypertension, v.25, no.4, pp.39 - 44
- Journal Title
- Clinical Hypertension
- Volume
- 25
- Number
- 4
- Start Page
- 39
- End Page
- 44
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/27983
- DOI
- 10.1186/s40885-019-0126-8
- ISSN
- 2635-6325
- Abstract
- Abstract Background: Pulmonary arterial hypertension (PAH) is a progressive, chronic disease without curative treatment.
Large registry data of these patient populations have been published, although, phenotypic variants within each subtype of PAH have not been elucidated. As interest towards personalized medicine grows, the need for a PAH cohort with a comprehensive understanding of patient phenotypes through multiomics approaches, called deep phenotyping, is on the rise. The PAH Platform for Deep Phenotyping in Korean Subjects (PHOENIKS) cohort is designed to collect clinical data as well as biological specimens for deep phenotyping in patients with idiopathic PAH (IPAH) and heritable PAH (HPAH) in Korea.
Methods: A total of 17 regional hospitals are currently working on enrolling up to 100 consecutive IPAH/HPAH patients for obtaining clinical data and biological specimens across Korea. The diagnosis of PAH is based on right heart catheterization. All clinical data is stored in a government-based online database. Each participating hospitals collect a whole blood sample from each patient, through which DNA, RNA, serum, plasma, and peripheral blood mononuclear cells will be extracted from the buffy coat layer for further multiomics analysis.
Results: Not applicable.
Conclusions: The PHOENIKS cohort is enrolling IPAH and HPAH patients across Korea to determine the prognosis and drug response in different phenotypic variant. The data generated by this cohort are expected to open new doors for personalized medicine in PAH patients of South Korea
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의예과 > 1. Journal Articles
- 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/27983)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.